Aarti Current Deferred Revenue from 2010 to 2025
| AARTIDRUGS | 425.85 4.95 1.18% |
Current Deferred Revenue | First Reported 2013-03-31 | Previous Quarter 11.8 M | Current Value 9.1 M | Quarterly Volatility 290.6 M |
Check Aarti Drugs financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Aarti Drugs' main balance sheet or income statement drivers, such as Depreciation And Amortization of 367.1 M, Interest Expense of 315 M or Selling General Administrative of 171.3 M, as well as many indicators such as . Aarti financial statements analysis is a perfect complement when working with Aarti Drugs Valuation or Volatility modules.
Aarti | Current Deferred Revenue |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Aarti Stock Analysis
When running Aarti Drugs' price analysis, check to measure Aarti Drugs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aarti Drugs is operating at the current time. Most of Aarti Drugs' value examination focuses on studying past and present price action to predict the probability of Aarti Drugs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aarti Drugs' price. Additionally, you may evaluate how the addition of Aarti Drugs to your portfolios can decrease your overall portfolio volatility.